80023448
TSKgel® UP-SW3000 (2 µm) HPLC Columns
L x I.D. 30 cm × 4.6 mm, diol phase
About This Item
Recommended Products
product name
TSKgel® UP-SW3000 HPLC Column, phase diol, L × I.D. 30 cm × 4.6 mm, 2 μm particle size
material
stainless steel
Agency
suitable for USP L20
suitable for USP L59
product line
TSKgel®
manufacturer/tradename
Tosoh 0023448
parameter
≤0.5 M salt concentration
0-30% aqueous soluble organic solvents
0.35 mL/min flow rate
10-30 °C temp. range
340 bar pressure
technique(s)
HPLC: suitable
L × I.D.
30 cm × 4.6 mm
matrix
silica particle platform
matrix active group
diol phase
particle size
2 μm
pore size
250 Å
pH range
2.5-7.5
separation technique
size exclusion (SEC)
Looking for similar products? Visit Product Comparison Guide
General description
Other Notes
Legal Information
antibody
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Articles
Size exclusion chromatography columns enhance biomolecule separation efficiency with sub-2 μm particles, improving analytical performance.
Size exclusion chromatography columns enhance biomolecule separation efficiency with sub-2 μm particles, improving analytical performance.
Size exclusion chromatography columns enhance biomolecule separation efficiency with sub-2 μm particles, improving analytical performance.
Size exclusion chromatography columns enhance biomolecule separation efficiency with sub-2 μm particles, improving analytical performance.
Protocols
New size exclusion chromatographic method characterizes bispecific antibodies for biotherapeutics development.
New size exclusion chromatographic method characterizes bispecific antibodies for biotherapeutics development.
New size exclusion chromatographic method characterizes bispecific antibodies for biotherapeutics development.
New size exclusion chromatographic method characterizes bispecific antibodies for biotherapeutics development.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service